Polynomial equations have long served as a cornerstone of mathematical analysis, offering a framework to understand functions, curves, and dynamic systems. In recent years, the study of these ...

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer Multicenter prospective ...

More specifically, a solution to the recurrence relation is a value that satisfies "if each child call terminates with probability t, the parent call terminates with probability t" but a solution to ...

Please provide your email address to receive an email when new articles are posted on . Microarray-trained models, which include molecular data, better predicted the recurrence of colorectal cancer ...

Access to Genetic Testing Impacts Oncologists´ Decisions on Ovarian Cancer Personalized Treatment: Lessons Learned From a National Program in Greece Data for reporting system-wide treatment activity ...

‒ Poster for GP2 Phase IIb clinical trial final efficacy analysis was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) today ‒ Phase IIb clinical trial was a prospective, ...

ST. LOUIS – A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer.

Poster published at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting shows the final 5 year safety data from the Phase IIb breast cancer clinical trial. Final safety conclusions ...

Forty-three percent of trials did not include data on post-recurrence treatment. Researchers identified a lack of data on post-recurrence treatment in trials supporting recent approvals of ...

"We believe ProSense® can make a significant impact on improving breast cancer outcomes in Japan by providing women with a minimally invasive option. This year's Conference was highly productive as we ...

(RTTNews) - The bladder cancer company Photocure ASA (PHCUF.PK), on Monday, announced the presentation of clinical data from the Veterans Affairs BRAVO study at the ASCO Genitourinary Cancers ...